Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE),  American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA). 

RSS icon
collet_and_colleagues_perform_ct-guided_pci.png

‘A defining moment’: How cardiologists can get the most out of CT-guided PCI

SCAI and SCCT have collaborated on a new document designed to get more interventional cardiologists to embrace CT-guided PCI going forward. 

Nabil Dib, MD, director clinical and translational research, Dignity Health, and founder of the non-profit International Society for Cardiovascular Translational Research (ISCTR), explains resources ISCTR has to help doctors and start ups navigate regulatory pathways to expedite moving from research to clinical application.

Nonprofit group helps doctors and startups bring new cardiovascular tech to market

Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications.

cardiologists heart doctors

Cardiologists share late-breaking TAVR data on first day of SCAI 2025

New TAVR data on SAPT vs. DAPT and prosthesis-patient mismatch among women were some of the many highlights of the conference's opening day.

Philippe Genereux, MD, director of the structural heart program at Morristown Medical Center, principal investigator of the late-breaking EARLY TAVR trial, presented new data at ACC 2025 showing intervening earlier on patients with asymptomatic severe aortic stenosis leads to better outcomes.

Latest EARLY TAVR data suggest it is time to update industry guidelines

Philippe Genereux, MD, principal investigator of EARLY TAVR, presented new data at ACC.25 showing intervening early on crossover patients with asymptomatic severe aortic stenosis led to better outcomes and a reduced stroke rate. 

Thumbnail

How radiotherapy protects the hearts of breast cancer patients

The study's authors reviewed CCTA imaging results taken before and after radiotherapy, evaluating each image for signs of coronary calcification and inflammation. 

Thumbnail

PFA associated with elevated risk of heart damage, real-world data show

Patient outcomes do not appear to be negatively impacted by these risks, researchers noted. The new data were presented at Heart Rhythm 2025 and published in JACC: Clinical Electrophysiology.

Partho Sengupta, MD, DM, FACC, FASE, Henry Rutgers Professor of Cardiology and Chief of Cardiovascular Medicine, at Robert Wood Johnson Medical School, and Chief of the Cardiovascular Service Line at Robert Wood Johnson University Hospital, offers an overview of the current state of artificial intelligence (AI) in cardiology. He offers insights from what he has seen from some of the more than 160 FDA-cleared algorithms specific to cardiovascular medicine and what is in development.

Exploring the evolution of AI in cardiology

Partho Sengupta, MD, shared his perspective on the current state of artificial intelligence in cardiology. The technology continues to evolve, he said, though it does still face certain limitations.

doctor with overweight patient who may be treated with TAVR or surgery

Bayer's finerenone reduces risk of AFib, atrial flutter in all CKM syndrome patients

New data published in JACC represents another big win for Bayer's finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD and heart failure, but its potential across the full CKM spectrum remained a bit of a mystery.

Displaying 401 - 408 of 1560
Design by Adaptive Theme